despit
ongo
medic
advanc
cardiovascular
diseas
continu
lead
health
concern
reninangiotensin
system
ra
play
import
role
regul
cardiovascular
function
therefor
subject
extens
studi
sever
drug
current
use
treat
hypertens
heart
failur
design
target
angiotensin
ii
synthesi
function
thu
far
none
abl
complet
block
effect
ra
signal
review
discuss
current
emerg
approach
toward
inhibit
cardiac
ra
function
order
improv
cardiovascular
diseas
outcom
cardiovascular
diseas
continu
lead
caus
death
reduc
qualiti
life
reninangiotensin
system
ra
effector
molecul
angiotensin
ang
ii
known
affect
wide
varieti
function
cardiovascular
renal
system
play
import
role
pathophysiolog
cardiovascular
diseas
therefor
consider
interest
year
understand
exactli
ra
function
regul
ra
thought
fairli
simpl
linear
cascad
oper
system
past
decad
becom
increasingli
clear
ra
actual
complex
system
includ
multipl
altern
pathway
feedback
mechan
fact
ra
function
local
well
system
local
function
may
differ
regul
involv
differ
compon
system
ra
particular
import
understand
impact
current
potenti
therapi
design
inhibit
pathophysiolog
effect
ang
ii
addit
discoveri
addit
ang
peptid
includ
ang
ang
ang
ang
ang
ang
made
clear
ang
ii
longer
view
act
isol
nevertheless
ang
ii
gener
still
consid
primari
effector
molecul
ra
impact
heart
directli
result
renal
vascular
effect
signific
role
vasoconstrict
mitochondri
function
thrombosi
fibrosi
hypertrophi
apoptosi
autophagi
ang
ii
intim
involv
cardiac
function
remodel
heart
failur
associ
ra
upregul
acut
myocardi
ischemiareperfus
significantli
increas
express
sever
major
cardiac
ra
compon
includ
ang
ii
review
focu
regul
ang
ii
heart
context
current
emerg
mode
intervent
classic
ra
angiotensinogen
produc
liver
enter
bloodstream
cleav
kidneyderiv
renin
form
decapeptid
ang
endotheli
cellbound
angiotensinconvert
enzym
ace
cleav
ang
produc
biolog
activ
octapeptid
ang
ii
ubiquit
express
ace
exist
membranebound
solubl
form
two
independ
catalyt
site
distinct
substrat
inhibitor
specif
ace
also
capabl
hydrolyz
varieti
substrat
includ
cardioprotect
agent
bradykinin
nacetylserylaspartyllysylprolin
tetrapeptid
ang
furthermor
ace
inhibitor
enhanc
kinin
receptor
signal
thu
ace
ang
iidepend
ang
iiindepend
effect
cardiovascular
function
logic
target
ra
regul
inde
ace
inhibit
reduc
blood
pressur
left
ventricular
hypertrophi
cardiac
inflamm
possibl
inactiv
spontan
hypertens
rat
clinic
studi
shown
variou
ace
inhibitor
effect
treat
congest
heart
failur
acut
myocardi
infarct
coronari
arteri
diseas
well
hypertens
sever
differ
ace
inhibitor
commerci
avail
current
guidelin
includ
use
ace
inhibitor
firstlin
therapi
patient
heart
failur
risk
heart
failur
howev
use
ace
inhibitor
associ
rel
high
incid
advers
effect
presum
owe
effect
kallikreinkinin
system
although
acut
ace
inhibit
decreas
plasma
ang
ii
chronic
treatment
result
escap
phenomenon
ang
ii
return
pretreat
level
mechan
involv
rebound
well
understood
evid
ace
may
involv
cellular
signal
addit
enzymat
role
protein
kinas
bind
phosphoryl
ser
ace
cytoplasm
tail
interact
enhanc
endotheli
cell
presenc
bradykinin
ace
inhibitor
phosphoryl
ace
activ
jnk
lead
nuclear
accumul
cjun
increas
ace
express
although
kohlstedt
et
al
suggest
ace
inhibitorinduc
increas
ace
express
may
somehow
contribut
benefici
effect
ace
inhibit
ace
signal
may
act
neg
feedback
mechan
ace
inhibit
becom
selflimit
hand
also
possibl
longterm
ace
inhibit
eventu
shift
balanc
toward
altern
chymasedepend
ang
ii
synthesi
pathway
although
ace
main
enzym
respons
system
ang
ii
synthesi
chymas
also
major
ang
iiform
enzym
human
heart
chymas
found
mainli
secretori
granul
mast
cell
remain
inact
releas
surround
interstiti
tissu
also
strongli
inhibit
endogen
serin
proteas
inhibitor
complex
heparin
proteoglycan
fact
togeth
exist
signific
speci
variabl
number
type
chymas
contribut
controversi
physiolog
role
chymas
accumul
evid
chymas
play
import
role
cardiac
tissu
format
ang
ii
particularli
pathophysiolog
condit
recent
wei
colleagu
demonstr
although
chymas
activ
interstiti
fluid
consciou
mice
neglig
basal
condit
chronic
ace
inhibit
markedli
increas
transcript
activ
ang
iiform
chymas
via
kinin
receptormast
celldepend
mechan
ang
ii
level
remain
unchang
addit
chymas
inhibitor
significantli
lower
ang
ii
level
demonstr
chymas
fact
respons
maintain
ang
ii
level
dual
treatment
ace
chymas
inhibitor
dramat
improv
left
ventricular
function
remodel
surviv
follow
myocardi
infarct
hamster
furthermor
recent
evid
suggest
ang
recent
discov
biolog
activ
ang
peptid
act
altern
precursor
ang
ii
chymas
respons
process
cardiac
tissu
addit
cleav
ang
peptid
chymas
also
appear
play
role
tissu
remodel
organ
damag
heart
failur
chymas
activ
transform
growth
increas
fibroblast
prolifer
collagen
deposit
matrix
involv
extracellular
matrix
turnov
thu
ace
inhibit
chymas
inhibit
potenti
could
provid
benefit
patient
cardiovascular
diseas
depend
independ
ang
ii
clearli
exist
altern
pathway
convers
ang
ang
ii
make
complet
inhibit
ra
problemat
point
mention
renin
function
upstream
ang
ii
format
convert
angiotensinogen
ang
circul
renin
origin
primarili
kidney
synthes
cleavag
precursor
prorenin
sourc
renin
involv
local
ang
ii
synthesi
less
clear
renin
express
level
cardiac
tissu
gener
low
basal
condit
howev
cardiac
renin
express
detect
certain
patholog
condit
diabet
nonsecret
truncat
activ
form
renin
induc
myocardi
infarct
addit
circul
prorenin
renin
bind
pro
renin
receptor
allow
contribut
local
ang
ii
synthesi
whether
cardiac
mast
cell
signific
sourc
renin
remain
controversi
may
depend
context
speci
number
direct
renin
inhibitor
exist
extens
studi
inhibitor
aliskiren
spontan
hypertens
rat
aliskiren
equival
ra
inhibitor
improv
coronari
endotheli
function
cardiac
hypertrophi
provid
superior
longterm
suppress
cardiac
angiotensin
similarli
diabetesinduc
intracellular
ang
ii
synthesi
adult
rat
cardiomyocyt
associ
oxid
stress
fibrosi
inhibit
effect
aliskiren
ra
inhibitor
though
approv
antihypertens
use
rel
effect
aliskiren
reduc
hypertens
still
matter
debat
though
studi
shown
aliskiren
superior
ra
inhibitor
other
shown
compar
superior
effect
although
direct
renin
inhibit
complet
inhibit
downstream
ra
function
aliskiren
longer
halflif
ra
inhibitor
absenc
neg
feedback
ang
ii
signal
lead
increas
plasma
reninprorenin
level
increas
reninprorenin
concentr
may
enhanc
pro
renin
receptor
signal
shown
activ
extracellular
signalregul
kinas
erk
ang
iiindepend
manner
even
presenc
aliskiren
although
physiolog
relev
pathway
vivo
remain
determin
altern
ang
may
serv
altern
substrat
ang
ii
format
absenc
renin
activ
therebi
limit
ang
ii
suppress
hand
evid
aliskiren
may
cardioprotect
effect
patient
left
ventricular
hypertrophi
heart
failur
ongo
studi
provid
addit
data
clinic
use
condit
associ
high
plasma
renin
activ
angiotensin
ii
type
receptor
blocker
ang
ii
bind
either
two
seventransmembran
g
proteincoupl
receptor
ang
ii
type
receptor
ang
ii
type
receptor
although
suggest
intracellular
ang
ii
may
intracrin
function
independ
known
function
ang
ii
involv
bind
receptor
exert
effect
g
protein
signal
heterodimer
transactiv
receptor
found
cell
surfac
bind
extracellular
ang
ii
rapidli
intern
well
mitochondria
nuclei
hand
limit
express
adult
organ
upregul
certain
pathophysiolog
condit
function
gener
oppos
blocker
arb
design
specif
inhibit
ang
iiinduc
signal
therefor
theoret
provid
complet
ra
blockad
intervent
block
one
altern
ang
ii
format
pathway
moreov
signal
induc
result
accumul
ang
ii
may
potenti
protect
effect
arb
clinic
trial
shown
arb
effect
reduc
hypertens
report
effect
arb
treat
cardiovascular
diseas
outcom
mix
result
may
due
part
absenc
rigor
dosag
optim
suggest
differenti
effect
high
low
dose
losartan
seen
heaal
studi
addit
small
differ
structur
differ
arb
proven
signific
impact
function
includ
effect
therefor
effect
given
arb
may
depend
specif
diseas
condit
current
guidelin
recommend
use
arb
patient
risk
heart
failur
altern
treatment
select
heart
failur
patient
intoler
ace
inhibitor
howev
recent
metaanalysi
found
arb
may
associ
increas
risk
cancer
suggest
investig
drug
warrant
protein
atrap
protein
upon
ang
ii
stimul
bind
carboxyltermin
cytoplasm
tail
cardiovascular
cell
promot
receptor
intern
act
endogen
inhibitor
although
physiolog
import
protein
need
clarif
appear
atrap
ratio
import
determin
effect
ang
ii
heart
ang
iiinduc
cardiac
hypertrophi
accompani
signific
decreas
atrap
express
wildtyp
mice
complet
abolish
transgen
mice
cardiomyocytespecif
overexpress
atrap
independ
effect
blood
pressur
thu
increas
atrap
express
could
novel
therapeut
option
inhibit
signal
cellpenetr
peptid
typic
short
cation
peptid
sequenc
use
deliv
protein
intact
cell
cellpenetr
peptid
consist
second
intracellular
loop
link
hivtransactiv
regulatori
protein
domain
effect
inhibit
function
mediat
second
intracellular
loop
previous
shown
unaffect
mutat
region
although
approach
requir
develop
complet
understand
mechan
involv
signal
studi
suggest
cellpenetr
peptid
potenti
may
use
take
advantag
bias
agon
observ
signal
serv
power
tool
select
regul
ang
ii
receptor
function
mention
ang
signal
gener
oppos
signal
trigger
accumul
ang
ii
may
partial
respons
antihypertens
effect
arb
induct
bradykininnitr
oxidemedi
vasodil
addit
may
ligandindepend
protect
effect
inhibit
signal
directli
heterodimer
two
receptor
constitut
inhibit
cardiomyocyt
autophagi
howev
signal
also
link
cardiac
hypertrophi
apoptosi
recent
studi
suggest
function
chang
relax
constrictor
upon
ang
ii
bind
hypertens
condit
nevertheless
direct
stimul
novel
nonpeptid
agonist
compound
inhibit
myocardi
infarctioninduc
apoptosi
inflamm
scar
format
systol
diastol
left
ventricular
dysfunct
suggest
direct
stimul
could
effect
way
prevent
cardiac
remodel
like
homolog
ace
zincmetallopeptidas
exist
membranebound
solubl
form
wherea
ace
synthes
ang
ii
ang
howev
serv
opposit
function
degrad
ang
ii
ang
addit
cleav
ang
ang
cleav
ace
give
ang
although
import
baselin
cardiac
function
somewhat
controversi
sever
studi
mice
rat
shown
protect
patholog
cardiac
remodel
dysfunct
owe
either
result
decreas
ang
ii
level
increas
biolog
activ
ang
degrad
ang
ii
obvious
import
part
function
synthesi
biolog
activ
cleavag
product
also
appear
play
import
role
mediat
cardioprotect
effect
degrad
product
ang
ii
ang
bind
ma
receptor
therebi
exert
effect
oppos
ang
ii
includ
inhibit
cardiac
hypertrophi
fibrosi
ang
also
shown
bind
ace
inhibit
bradykinin
degrad
well
inhibit
former
stimul
latter
ang
form
cleavag
ang
either
carboxypeptidas
though
ang
thought
simpli
stabl
intermediari
ang
product
shown
biolog
activ
right
administr
ang
follow
myocardi
infarct
rat
decreas
plasma
ang
ii
inhibit
ace
activ
prevent
cardiomyocyt
hypertrophi
furthermor
treatment
myocardi
infarct
rat
either
ace
inhibitor
arb
led
increas
circul
ang
ang
suggest
ang
may
import
cardioprotect
factor
express
inhibit
ang
ii
upregul
treatment
ace
inhibitor
arb
suggest
may
contribut
effect
drug
may
good
candid
therapeut
intervent
possibl
approach
increas
activ
includ
use
smallmolecul
activ
xnt
dimethylamino
ethyl
amino
hydroxymethyl
sulfonyl
oxi
gene
transfer
therapi
investig
warrant
howev
longterm
extrem
overexpress
result
sever
cardiac
fibrosi
strokepron
spontan
hypertens
rat
recent
identifi
receptor
sever
acut
respiratori
syndrom
sar
viru
ang
level
increas
ace
inhibitor
arb
treatment
suggest
play
role
benefici
effect
drug
howev
ang
short
halflif
make
unsuit
direct
therapeut
use
altern
ma
agonist
well
approach
increas
stabil
ang
current
investig
patient
adher
daili
medic
regimen
problemat
vaccin
administ
sever
time
year
may
effect
mode
treatment
although
earli
attempt
develop
vaccin
renin
ang
success
recent
work
ang
ii
vaccin
appear
promis
initi
test
dose
significantli
reduc
blood
pressur
appear
well
toler
studi
requir
howev
determin
longterm
efficaci
safeti
vaccin
somewhat
differ
approach
inject
antibodi
ctermin
fragment
kardo
also
appear
antihypertens
effect
current
investig
ongo
advanc
modern
medicin
led
develop
mani
effect
treatment
option
hypertens
cardiovascular
diseas
nevertheless
morbid
mortal
relat
cardiovascular
diseas
remain
high
ra
play
import
role
determin
cardiovascular
function
sever
current
use
therapeut
approach
specif
target
critic
point
ra
signal
pathway
howev
exist
altern
synthesi
signal
pathway
tight
regul
via
posit
neg
feedback
loop
goal
complet
inhibit
effect
ang
ii
remain
elus
extent
ang
ii
exert
effect
via
pathway
depend
blood
pressur
independ
remain
matter
debat
prompt
argu
main
focu
treatment
regimen
blood
pressur
control
rather
specif
target
ra
hand
drug
chosen
effect
control
hypertens
may
optim
prevent
organ
damag
may
requir
optim
treatment
heart
failur
combin
multipl
ra
inhibitor
also
heavili
investig
mean
complet
inhibit
ra
function
remain
controversi
understand
mechan
involv
ra
function
inhibit
grow
howev
becom
possibl
improv
patient
outcom
ongo
discoveri
new
function
current
drug
well
new
potenti
therapeut
target
indic
still
much
learn
great
potenti
effect
cardiovascular
treatment
disclosur
potenti
conflict
interest
relev
articl
report
studi
describ
previous
unknown
function
ra
provid
first
evid
ang
ii
receptor
involv
regul
autophagi
heart
